Abstract:An appropriate conventional method has been utilised to synthesise new tridentate Schiff base ligand 4-chloro-2-((2,4-dihydroxybenzylidene)amino)benzoic acid with Co (II), Ni (II), Cu (II), and Zn (II) complexes. Several spectroscopic(FT-IR, 1 H NMR, 13 C NMR, UV–Vis, Mass), TGA-DTA, powder X-ray diffraction, and DFT calculations, were used to characterise these complexes.According to these spectroscopic investigations, the ligand coordinated with the metals via carboxylic oxygen, azomethine nitrogen, and hydroxyl oxygen, acting as a tridentate ligand. Appropriate geometry for every complex has been proposed based on spectroscopic and analytical data. In tetrahedral geometry with Co(II), Ni(II), Zn(II), and square planner with Cu(II) ion, the ligand functions as a tridentate via ONO donors.The optimal structure (bond length and bond angle) and chemical reactivity of the ligand and its metal complexes from their Frontier Molecular Orbitals (FMO) and Molecular electrostatic potential (MESP) calculations have been investigated using Density Functional Theory (DFT/B3LYP,6-31G**/6-311G**(d,p), and LanL2DZ basis sets) calculations. In vitro DPPH radical scavenging techniques were used to assess the antioxidant activity of the ligand and its metal complexes. The results indicated that all of the complexes exhibited good antioxidant activity, with Cu (II) complex being the most potent with the lowest IC 50 values.The ligand and complexes' in vitro antibacterial activities were further explored by screening them against Gram(+ve) bacteria (Bacillus subtilis) and Gram(−ve) bacteria (E. coli) . Significant activity was demonstrated by all synthesised compounds against the tested strains of bacteria. The antifungal activity of complexes against Aspergillus niger and Candida albicans was determined. The results indicated that Cu (II) complex exhibited good antifungal activity against Candida albicans , but not against Aspergillus niger . The fungal strain Aspergillus niger was not significantly inhibited by complexes. The complexes have greater antimicrobial activity than the Schiff base ligand, as indicated by the MIC values.

Ceftriaxone-based Schiff base transition metal(II) complexes. Synthesis, characterization, bacterial toxicity, and DFT calculations. Enhanced antibacterial activity of a novel Zn(II) complex against S. aureus and E. coli

Synthesis, characterization and antibacterial activity of a Schiff base derived from cephalexin and sulphathiazole and its transition metal complexes

Transition Metal Ion Complexes of Schiff‐bases. Synthesis, Characterization and Antibacterial Properties

Syntheses, Crystal Structures and Antitumor Activity of Ni((II)/Zn(II) Complexes Containing Cephalexin Hydrolysate

Synthesis and characterization of novel metal complexes with new azo-schiff base ligand derived from sulfa drug and toxicological studies of its complexes as antibacterial

Synthesis and Antibacterial Activities of Metal(ii) Complexes with Schiff Bases Derived from 3,5-Diiodosalicylaldehyde

Synthesis, Characterization and Biological Activity of Transition Metals Schiff Base Complexes Derived from 4,6-Diacetylresorcinol and 1,8-Naphthalenediamine

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

Synthesis, spectral studies and antimicrobial evaluation of transition metal complexes of bidentate Schiff base ligands derived from 4-amino quinoline

Anion Induced Synthesis and Crystal Structures of Schiff Base Copper(II) and Zinc(II) Complexes with Antibacterial Activity

SYNTHESIS, CHARACTRIZATION AND ANTIBACTERIAL ACTIVITY OF SCHIFF BASES DERIVED FROM PHENYL HYDRAZINE DERIVATIVES AND THEIR Cu (II) and Zn (II) COMPLEXES

Nickel(II), copper(II) and zinc(II) complexes containing symmetrical Tetradentate Schiff base ligand derived from 3,5-diiodosalicylaldehyde: Synthesis, characterization, crystal structure and antimicrobial activity

Synthesis of biologically active cefpodoxime and vanillin-based schiff base metal complexes with the detailed biological evaluations

Zinc complexes of benzothiazole-derived Schiff bases with antibacterial activity

Synthesis, Spectroscopic, Chemical Characterizations, Anticancer Capacities against HepG-2, Antibacterial and Antioxidant Activities of Cefotaxime Metal Complexes with Ca(II), Cr(III), Zn(II), Cu(II) and Se(IV)

Preparation, Characterization, DFT Calculations, Antibacterial and Molecular Docking Study of Co(II), Cu(II), and Zn(II) Mixed Ligand Complexes

Manganese(II) and Zinc(II) metal complexes of novel bidentate formamide-based Schiff base ligand: synthesis, structural characterization, antioxidant, antibacterial, and in-silico molecular docking study

Synthesis, spectroscopic, biological and structural characterizations for the gold(III), platinum(IV), and Ruthenium(III) ceftriaxone drug complexes

Synthesis, crystal structure and antibacterial activity of zinc(II) complexes with Schiff bases derived from 5-fluorosalicylaldehyde

Syntheses, Characterization and Crystal Structures of Schiff Base Zinc(II) Complexes with Antibacterial Activity.